Skip to main content
Hide Menu
Show Menu
HRCS
ONLINE
Home
Getting started
Health categories
Research activities
Guidance
Reports
UKCRC Health Research Classification System
Search for:
Search
Home
Reports
Additional resources
whats it worth summary
2018redirect
2014public_tableau
2018public
2014 redirect
2009redirect
Front Page
Getting started
Purpose of the HRCS
Use of the HRCS
Conditions of use
History
General approach to coding
Assigning health categories
Assigning research activities
Common mistakes
Training
Trainer Resources
Health Categories
Blood
Cancer and neoplasms
Cardiovascular
Congenital disorders
Ear
Eye
Infection
Inflammatory and immune system
Injuries and accidents
Mental health
Metabolic and Endocrine
Musculoskeletal
Neurological
Oral and Gastrointestinal
Renal and Urogenital
Reproductive health and childbirth
Respiratory
Skin
Stroke
Generic health relevance
Disputed Aetiology and Other
Research activities
1. Underpinning research
1.1 Normal biological development and functioning
1.2 Psychological and socioeconomic process
1.3 Chemical and physical sciences
1.4 Methodologies and measurements
1.5 Resources and infrastructure
2. Aetiology
2.1 Biological and endogenous factors
2.2 Factors relating to physical environment
2.3 Psychological, social and economic factors
2.4 Surveillance and distribution
2.5 Research design and methodologies (aetiology)
2.6 Resources and infrastructure (aetiology)
3. Prevention of disease and conditions
3.1 Primary prevention interventions to modify behaviours or promote well-being
3.2 Interventions to alter physical and biological environmental risks
3.3 Nutrition and chemoprevention
3.4 Vaccines
3.5 Resources and infrastructure (prevention)
4. Detection screening and diagnosis
4.1 Discovery and preclinical testing of markers and technologies
4.2 Evaluation of markers and technologies
4.3 Influences and impact
4.4 Population screening
4.5 Resources and infrastructure (detection)
5. Development of treatments and therapeutic interventions
5.1 Pharmaceuticals
5.2 Cellular and gene therapies
5.3 Medical devices
5.4 Surgery
5.5 Radiotherapy and other non-invasive therapies
5.6 Psychological and behavioural
5.7 Physical
5.8 Complementary
5.9 Resources and infrastructure (treatment development)
6. Evaluation of treatments and therapeutic interventions
6.1 Pharmaceuticals
6.2 Cellular and gene therapies
6.3 Medical devices
6.4 Surgery
6.5 Radiotherapy and other non-invasive therapies
6.6 Psychological and behavioural
6.7 Physical
6.8 Complementary
6.9 Resources and infrastructure (treatment evaluation)
7. Management of diseases and conditions
7.1 Individual care needs
7.2 End of life care
7.3 Management and decision making
7.4 Resources and infrastructure (disease management)
8. Health and social care services research
8.1 Organisation and delivery of services
8.2 Health and welfare economics
8.3 Policy, ethics and research governance
8.4 Research design and methodologies
8.5 Resources and infrastructure (health services)
Guidance
Ageing
Alcohol consumption
Animal welfare and replacing animals in research
Atherosclerosis
Biomarkers and screening
Cachexia in chronic diseases and chemotherapy
Cancer and conditions predisposing to cancer
Case studies and tracer examples
Cell cycle and DNA repair
Cerebral palsy and spina bifida
Cholesterol
Co-morbidities
Congenital disorders and inherited syndromes
Developmental biology
Diet, obesity and nutrition
Ear and hearing
Economic evaluation components in trials
Education
Eye and vision
Foetal development, pregnancy and ‘in utero’ studies
Immunology and immune system
Infectious diseases
Informatics, Bioinformatics and ‘Big Data’
Liver
Methodologies, measurements and research designs
Multiple diseases and categories
Muscle and neuromuscular junction
Neuropsychology
Nutritional and vitamin supplements
Pain
Pharmaceuticals outside the therapeutic context
Physical activity and exercise
Policy
Pollution, radiation and environmental hazards
Prevention – differentiating primary and secondary
Prions – studies of TSEs, BSE, CJD and prion protein
Pulmonary hypertension
Quality of life components in trials
Resources and infrastructure
Sepsis
Sequelae, consequences and side effects
Sexual health
Sleep and studies of sleep disorders
Smoking and tobacco
Stem cells
Stratified Medicine, Precision Medicine and Personalised Medicine
Substance misuse and addiction
Surgical procedures
Systematic reviews
Thromboses and embolisms
Treatment effectiveness
Trials
Vasculitis
Vertigo and disorders of balance
Wounds and healing
Reports
Analysis reports
UK Health Research Analysis 2022
Analysis 2022 – Submission Guidance
Analysis 2022 – Frequently Asked Questions
Anaylsis 2022 – Data Publicity Statement
Analysis 2022 – Qualitative submissions
UK Health Research Analysis 2018
Analysis 2018 – news and wider use
UK Health Research Analysis 2014
2014 analysis – news and wider use
UK Health Research Analysis 2009/10
HRCS International Workshop 2009
From Donation to Innovation (2007)
UK Health Research Analysis 2004/05
Analysis data
Analysis tools
Additional resources
Blog
Contact us
Terms and Conditions
Data protection
Privacy notice
Cookies policy
Accessibility
whats it worth summary
https://hrcsonline.net/wp-content/uploads/2019/10/whats-it-worth-summary.png
Top